Showing results (41-50 of 200) with videos related to
Sort By:
Pageof 20
Cancers|July 31, 2020
Carcinoma-Associated Mesenchymal Stem Cells Promote Chemoresistance in Ovarian Cancer Stem Cells via PDGF SignalingShreya Raghavan, Catherine S Snyder, Anni Wang, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 11, 2022
Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: a case seriesTiffany Y Sia, Beryl Manning-Geist, Sushmita Gordhandas, et al.Cancer Medicine|April 19, 2018
Adjuvant chemotherapy in patients with operable granulosa cell tumors of the ovary: a surveillance, epidemiology, and end results cohort studyAnton Oseledchyk, Renee L Gennarelli, Mario M Leitao, et al.Journal of the National Cancer Institute|August 16, 2020
Recommendations for Testing and Treating Outpatient Cancer Patients in the Era of COVID-19Diane Reidy-Lagunes, Leonard Saltz, Michael Postow, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2018
Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic EfficacyJacob M Ricca, Anton Oseledchyk, Tyler Walther, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancerEric Rios-Doria, Nadeem R Abu-Rustum, Kaled M Alektiar, et al.NPJ Precision Oncology|January 9, 2024
Cancer associated fibroblasts serve as an ovarian cancer stem cell niche through noncanonical Wnt5a signalingYiming Fang, Xue Xiao, Ji Wang, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 23, 2024
Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancerEric Rios-Doria, Nadeem R Abu-Rustum, Kaled M Alektiar, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2009
Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responsesDmitriy Zamarin, Luis Martínez-Sobrido, Kaitlyn Kelly, et al.Cell Reports|September 29, 2015
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent MannerRikke B Holmgaard, Dmitriy Zamarin, Yanyun Li, et al.Pageof 20